Take Your Steps: Hierarchically Efficient Pulmonary Disease Screening via CT Volume Compression

Deep learning models are widely used to process Computed Tomography (CT) data in the automated screening of pulmonary diseases, significantly reducing the workload of physicians. However, the three-dimensional nature of CT volumes involves an excessive number of voxels, which significantly increases the complexity of model processing. Previous screening approaches often overlook this issue, which undoubtedly reduces screening efficiency. Towards efficient and effective screening, we design a hierarchical approach to reduce the computational cost of pulmonary disease screening. The new approach re-organizes the screening workflows into three steps. First, we propose a Computed Tomography Volume Compression (CTVC) method to select a small slice subset that comprehensively represents the whole CT volume. Second, the selected CT slices are used to detect pulmonary diseases coarsely via a lightweight classification model. Third, an uncertainty measurement strategy is applied to identify samples with low diagnostic confidence, which are re-detected by radiologists. Experiments on two public pulmonary disease datasets demonstrate that our approach achieves comparable accuracy and recall while reducing the time by 50%-70% compared with the counterparts using full CT volumes. Besides, we also found that our approach outperforms previous cutting-edge CTVC methods in retaining important indications after compression.

S$^2$ALM: Sequence-Structure Pre-trained Large Language Model for Comprehensive Antibody Representation Learning

Antibodies safeguard our health through their precise and potent binding to specific antigens, demonstrating promising therapeutic efficacy in the treatment of numerous diseases, including COVID-19. Recent advancements in biomedical language models have shown the great potential to interpret complex biological structures and functions. However, existing antibody specific models have a notable limitation that they lack explicit consideration for antibody structural information, despite the fact that both 1D sequence and 3D structure carry unique and complementary insights into antibody behavior and functionality. This paper proposes Sequence-Structure multi-level pre-trained Antibody Language Model (S$^2$ALM), combining holistic sequential and structural information in one unified, generic antibody foundation model. We construct a hierarchical pre-training paradigm incorporated with two customized multi-level training objectives to facilitate the modeling of comprehensive antibody representations. S$^2$ALM's representation space uncovers inherent functional binding mechanisms, biological evolution properties and structural interaction patterns. Pre-trained over 75 million sequences and 11.7 million structures, S$^2$ALM can be adopted for diverse downstream tasks: accurately predicting antigen-antibody binding affinities, precisely distinguishing B cell maturation stages, identifying antibody crucial binding positions, and specifically designing novel coronavirus-binding antibodies. Remarkably, S$^2$ALM outperforms well-established and renowned baselines and sets new state-of-the-art performance across extensive antibody specific understanding and generation tasks. S$^2$ALM's ability to model comprehensive and generalized representations further positions its potential to advance real-world therapeutic antibody development, potentially addressing unmet academic, industrial, and clinical needs.

Medical Video Generation for Disease Progression Simulation

Modeling disease progression is crucial for improving the quality and efficacy of clinical diagnosis and prognosis, but it is often hindered by a lack of longitudinal medical image monitoring for individual patients. To address this challenge, we propose the first Medical Video Generation (MVG) framework that enables controlled manipulation of disease-related image and video features, allowing precise, realistic, and personalized simulations of disease progression. Our approach begins by leveraging large language models (LLMs) to recaption prompt for disease trajectory. Next, a controllable multi-round diffusion model simulates the disease progression state for each patient, creating realistic intermediate disease state sequence. Finally, a diffusion-based video transition generation model interpolates disease progression between these states. We validate our framework across three medical imaging domains: chest X-ray, fundus photography, and skin image. Our results demonstrate that MVG significantly outperforms baseline models in generating coherent and clinically plausible disease trajectories. Two user studies by veteran physicians, provide further validation and insights into the clinical utility of the generated sequences. MVG has the potential to assist healthcare providers in modeling disease trajectories, interpolating missing medical image data, and enhancing medical education through realistic, dynamic visualizations of disease progression.

AnyECG: Foundational Models for Electrocardiogram Analysis

Electrocardiogram (ECG), a non-invasive and affordable tool for cardiac monitoring, is highly sensitive in detecting acute heart attacks. However, due to the lengthy nature of ECG recordings, numerous machine learning methods have been developed for automated heart disease detection to reduce human workload. Despite these efforts, performance remains suboptimal. A key obstacle is the inherent complexity of ECG data, which includes heterogeneity (e.g., varying sampling rates), high levels of noise, demographic-related pattern shifts, and intricate rhythm-event associations. To overcome these challenges, this paper introduces AnyECG, a foundational model designed to extract robust representations from any real-world ECG data. Specifically, a tailored ECG Tokenizer encodes each fixed-duration ECG fragment into a token and, guided by proxy tasks, converts noisy, continuous ECG features into discrete, compact, and clinically meaningful local rhythm codes. These codes encapsulate basic morphological, frequency, and demographic information (e.g., sex), effectively mitigating signal noise. We further pre-train the AnyECG to learn rhythmic pattern associations across ECG tokens, enabling the capture of cardiac event semantics. By being jointly pre-trained on diverse ECG data sources, AnyECG is capable of generalizing across a wide range of downstream tasks where ECG signals are recorded from various devices and scenarios. Experimental results in anomaly detection, arrhythmia detection, corrupted lead generation, and ultra-long ECG signal analysis demonstrate that AnyECG learns common ECG knowledge from data and significantly outperforms cutting-edge methods in each respective task.

Protein-Mamba: Biological Mamba Models for Protein Function Prediction

Protein function prediction is a pivotal task in drug discovery, significantly impacting the development of effective and safe therapeutics. Traditional machine learning models often struggle with the complexity and variability inherent in predicting protein functions, necessitating more sophisticated approaches. In this work, we introduce Protein-Mamba, a novel two-stage model that leverages both self-supervised learning and fine-tuning to improve protein function prediction. The pre-training stage allows the model to capture general chemical structures and relationships from large, unlabeled datasets, while the fine-tuning stage refines these insights using specific labeled datasets, resulting in superior prediction performance. Our extensive experiments demonstrate that Protein-Mamba achieves competitive performance, compared with a couple of state-of-the-art methods across a range of protein function datasets. This model's ability to effectively utilize both unlabeled and labeled data highlights the potential of self-supervised learning in advancing protein function prediction and offers a promising direction for future research in drug discovery.

Quantum-inspired Reinforcement Learning for Synthesizable Drug Design

Synthesizable molecular design (also known as synthesizable molecular optimization) is a fundamental problem in drug discovery, and involves designing novel molecular structures to improve their properties according to drug-relevant oracle functions (i.e., objective) while ensuring synthetic feasibility. However, existing methods are mostly based on random search. To address this issue, in this paper, we introduce a novel approach using the reinforcement learning method with quantum-inspired simulated annealing policy neural network to navigate the vast discrete space of chemical structures intelligently. Specifically, we employ a deterministic REINFORCE algorithm using policy neural networks to output transitional probability to guide state transitions and local search using genetic algorithm to refine solutions to a local optimum within each iteration. Our methods are evaluated with the Practical Molecular Optimization (PMO) benchmark framework with a 10K query budget. We further showcase the competitive performance of our method by comparing it against the state-of-the-art genetic algorithms-based method.

Quantum-machine-assisted Drug Discovery: Survey and Perspective

Drug discovery and development is a highly complex and costly endeavor, typically requiring over a decade and substantial financial investment to bring a new drug to market. Traditional computer-aided drug design (CADD) has made significant progress in accelerating this process, but the development of quantum computing offers potential due to its unique capabilities. This paper discusses the integration of quantum computing into drug discovery and development, focusing on how quantum technologies might accelerate and enhance various stages of the drug development cycle. Specifically, we explore the application of quantum computing in addressing challenges related to drug discovery, such as molecular simulation and the prediction of drug-target interactions, as well as the optimization of clinical trial outcomes. By leveraging the inherent capabilities of quantum computing, we might be able to reduce the time and cost associated with bringing new drugs to market, ultimately benefiting public health.

Cross-composition Feature Disentanglement for Compositional Zero-shot Learning

Disentanglement of visual features of primitives (i.e., attributes and objects) has shown exceptional results in Compositional Zero-shot Learning (CZSL). However, due to the feature divergence of an attribute (resp. object) when combined with different objects (resp. attributes), it is challenging to learn disentangled primitive features that are general across different compositions. To this end, we propose the solution of cross-composition feature disentanglement, which takes multiple primitive-sharing compositions as inputs and constrains the disentangled primitive features to be general across these compositions. More specifically, we leverage a compositional graph to define the overall primitive-sharing relationships between compositions, and build a task-specific architecture upon the recently successful large pre-trained vision-language model (VLM) CLIP, with dual cross-composition disentangling adapters (called L-Adapter and V-Adapter) inserted into CLIP's frozen text and image encoders, respectively. Evaluation on three popular CZSL benchmarks shows that our proposed solution significantly improves the performance of CZSL, and its components have been verified by solid ablation studies.

TeleOR: Real-time Telemedicine System for Full-Scene Operating Room

The advent of telemedicine represents a transformative development in leveraging technology to extend the reach of specialized medical expertise to remote surgeries, a field where the immediacy of expert guidance is paramount. However, the intricate dynamics of Operating Room (OR) scene pose unique challenges for telemedicine, particularly in achieving high-fidelity, real-time scene reconstruction and transmission amidst obstructions and bandwidth limitations. This paper introduces TeleOR, a pioneering system designed to address these challenges through real-time OR scene reconstruction for Tele-intervention. TeleOR distinguishes itself with three innovative approaches: dynamic self-calibration, which leverages inherent scene features for calibration without the need for preset markers, allowing for obstacle avoidance and real-time camera adjustment; selective OR reconstruction, focusing on dynamically changing scene segments to reduce reconstruction complexity; and viewport-adaptive transmission, optimizing data transmission based on real-time client feedback to efficiently deliver high-quality 3D reconstructions within bandwidth constraints. Comprehensive experiments on the 4D-OR surgical scene dataset demostrate the superiority and applicability of TeleOR, illuminating the potential to revolutionize tele-interventions by overcoming the spatial and technical barriers inherent in remote surgical guidance.

Multi-Modal CLIP-Informed Protein Editing

Proteins govern most biological functions essential for life, but achieving controllable protein discovery and optimization remains challenging. Recently, machine learning-assisted protein editing (MLPE) has shown promise in accelerating optimization cycles and reducing experimental workloads. However, current methods struggle with the vast combinatorial space of potential protein edits and cannot explicitly conduct protein editing using biotext instructions, limiting their interactivity with human feedback. To fill these gaps, we propose a novel method called ProtET for efficient CLIP-informed protein editing through multi-modality learning. Our approach comprises two stages: in the pretraining stage, contrastive learning aligns protein-biotext representations encoded by two large language models (LLMs), respectively. Subsequently, during the protein editing stage, the fused features from editing instruction texts and original protein sequences serve as the final editing condition for generating target protein sequences. Comprehensive experiments demonstrated the superiority of ProtET in editing proteins to enhance human-expected functionality across multiple attribute domains, including enzyme catalytic activity, protein stability and antibody specific binding ability. And ProtET improves the state-of-the-art results by a large margin, leading to significant stability improvements of 16.67% and 16.90%. This capability positions ProtET to advance real-world artificial protein editing, potentially addressing unmet academic, industrial, and clinical needs.